January 16th 2023
By Brielle Benyon
Virtual oncology visits may lessen the financial toxicity of cancer treatments, according to recent research.
December 28th 2022
By Martha Carlson
Having cancer care denied or delayed is not a harmless situation when your life is on the line.
November 1st 2022
When people say. “It’s just $35 to see a specialist,” they miss the entire issue of cancer-related financial toxicity.
September 24th 2022
By Ryan McDonald
CURE®’s Lung Cancer Heroes® Award Program honors and gives thanks to those heroes who have positively affected the lives of patients with lung cancer.
September 20th 2022
Pets may be like family to some individuals but caring for them during illnesses such as cancer may force some to make a difficult decision.
August 4th 2022
Cancer-related pain, especially when severe, is associated with negative effects on patients’ employment and financial status, recent findings showed.
June 24th 2022
By Debbie Legault
I can’t imagine my daughter not getting important cancer treatments because we could not afford it or because insurance denied it. Unfortunately, that is the situation for many patients.
June 21st 2022
By Mark Cantrell
Many patients with cancer who have limited financial resources or high insurance co-pays have started to use crowdfunding campaigns to pay for the daunting bills associated with their treatment and subsequent care.
March 15th 2022
As the average price of regular-grade gas in the United States speeds past $4.30 a gallon, many patients with cancer may be wondering how they can afford to get to and from cancer treatments. Luckily, there’s assistance to make travel less expensive.
March 9th 2022
By Katherine Malmo
Although multiple myeloma survival rates have improved over the past 20 years, the survival gap among socioeconomic groups has widened.
November 1st 2021
By Darlene Dobkowski, MA
When patients with cancer are faced with receiving a prior authorization from their insurance provider for oral anticancer drugs, it is important that they advocate for themselves, according to an expert.
October 28th 2021
“The financial burden is another gift that cancer keeps on giving,” writes the mother and caregiver of a young woman with breast cancer.
October 20th 2021
By Antonia DePace
Talking with a doctor about costly cancer treatments and being frank with health care teams can ease financial distress for patients with cancer.
August 11th 2021
By Colleen Moretti
“More and more (patients and physicians) need to work together in partnership throughout the cancer journey in order to optimize and make the journey the best possible that we can for every single patient,” says an expert from the Roswell Park Comprehensive Cancer Center.
August 3rd 2021
Experts urge parents to continue to have conversations with their children about the financial hardships that may occur because of a pediatric cancer diagnosis.
July 14th 2021
By Marissa Holzer
A woman with metastatic cancer explains how she found a copay assistance program and specialty pharmacy to help manage the cost of pricey medications, though not without a few bumps in the road.
July 13th 2021
Newer cancer therapies easily cost upward of $100,000. Why so much? Who sets the prices and what can patients do if they can't afford them?
July 12th 2021
Parents who receive a diagnosis of cancer are often faced with the trials of prioritizing themselves over their children, causing stress, burnout and disruption in cancer care.
June 14th 2021
To avoid the financial burden of costly therapies, patients with cancer receiving immunotherapy treatments should talk with their health care team and not settle for no as an answer from their health insurance provider, according to an expert.
June 2nd 2021
By Bonnie Annis
A senior cancer survivor shares her experiences with post-cancer finances and offers some advice to others in the same situation.
May 20th 2021
A patient offers advice on getting patient portals, electronic medical records and technology organized and functioning correctly.
May 19th 2021
Survival rates in this study were similar across cancer types including colorectal and prostate cancers, which may indicate a need for updated policies to include more patients.
April 29th 2021
By Jamie Cesanek
As transportation to treatments is one of the many important aspects patients with cancer must consider after receiving a diagnosis, there is room for improvement in terms of accessibility and affordability, says an expert from the Patient Access Network Foundation.
April 15th 2021
By Steve Rubin
Navigating medical leave and insurance forms can be nerve-wracking and feel high stakes for some, writes a cancer survivor. Here, he offers advice on how to manage that stress.
April 1st 2021
By Kristie L. Kahl
CURE spoke with a cancer rights attorney about what financial toxicity is and ways to address this burden before assistance is needed.
March 31st 2021
CURE® spoke with a cancer rights attorney about employment rights and how patients and their caregivers can learn more to ensure they are being protected.
March 29th 2021
Recent study results show an association between living in an area of socioeconomic deprivation and poor outcomes for patients with cancer who were treated in clinical trials.
March 25th 2021
CURE® spoke with Monica Fawzy Bryant, chief operating officer of Triage Cancer, about health insurance options and what patients with cancer need to know.
March 10th 2021
By The PAN Foundation
George Valentine needs something from his elected representatives in Congress: securing predictable annual out-of-pocket costs under Medicare Part D’s prescription drug plan.
January 22nd 2021
By Conor Killmurray
From a Marine veteran walking 8,500 miles over the last 24 years to raise cancer awareness and funds for treatment to researchers using cancer cells from a deceased osteosarcoma donor to help advance treatment, here’s what’s happening in the cancer landscape this week.
Drug Offers Long-Term Heart Protection for Childhood Cancer Survivors
Breast Cancer Treatment Recommendations May Differ From Ages 69 to 70
The Sci-Fi World of Cancer Treatment
FDA OKs Study of Novel CAR-T Cell Therapy for Myeloma